This company has been marked as potentially delisted and may not be actively trading. Bellerophon Therapeutics (BLPH) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisDividendInsider TradesSustainabilityTrendsBuy This Stock Bellerophon Therapeutics (NASDAQ:BLPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.20%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$5.61 M Get BLPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BLPH Insider Buying and Selling by Quarter Bellerophon Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/13/2023Puissance Capital Management LMajor ShareholderSell1,076,841$0.10$107,684.10 6/7/2023Life Science Opportu PuissanceMajor ShareholderSell134,421$0.83$111,569.43 5/18/2023Bobae KimVPSell9,455$10.00$94,550.00 5/18/2023Life Science Opportu PuissanceMajor ShareholderSell560,000$9.46$5,297,600.00 (Data available from 1/1/2013 forward) BLPH Insider Trading Activity - Frequently Asked Questions Who is on Bellerophon Therapeutics's Insider Roster? The list of insiders at Bellerophon Therapeutics includes Bobae Kim, Life Science Opportu Puissance, and Puissance Capital Management L. Learn more on insiders at BLPH. What percentage of Bellerophon Therapeutics stock is owned by insiders? 5.20% of Bellerophon Therapeutics stock is owned by insiders. Learn more on BLPH's insider holdings. Which Bellerophon Therapeutics insiders have been selling company stock? The following insiders have sold BLPH shares in the last 24 months: Bobae Kim ($94,550.00), Life Science Opportu Puissance ($5,409,169.43), and Puissance Capital Management L ($107,684.10). How much insider selling is happening at Bellerophon Therapeutics? Insiders have sold a total of 1,780,717 Bellerophon Therapeutics shares in the last 24 months for a total of $5,611,403.53 sold. Bellerophon Therapeutics Key ExecutivesMr. Craig R. Jalbert CIRA (Age 62)President, Treasurer, Secretary, Principal Executive, Financial & Accounting Officer and Director More Insider Trading Tools from MarketBeat Related Companies Sorrento Therapeutics Insider Trades Biora Therapeutics Insider Trades MyMD Pharmaceuticals Insider Trades Virpax Pharmaceuticals Insider Trades TFF Pharmaceuticals Insider Trades TC Biopharm Insider Trades Aditxt Insider Trades Vaxxinity Insider Trades Calithera Biosciences Insider Trades Evelo Biosciences Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:BLPH) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellerophon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellerophon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLPH Stock Free BLPH Stock Alerts